Calcium with ergocalciferol oral
- Drugs List
- Therapeutic Indications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
Oral formulations of calcium with ergocalciferol.
Treatment of calcium and vitamin D deficiency
Calcium and vitamin D deficiency
One tablet daily.
Severe calcium and vitamin D deficiency
As directed by physician.
The manufacturer recommends to use as directed by a physician.
Other sources suggest that calcium and ergocalciferol tablets are not licensed for use in children under 6 years of age.
Hereditary fructose intolerance
Prolonged immobilisation with hypercalciuria and/or hypercalcaemia
Severe renal impairment
Precautions and Warnings
Children under 6 years
Predisposition to nephrolithiasis
Glucose-galactose malabsorption syndrome
History of nephrolithiasis
Malabsorption associated with chronic gastrointestinal disorders
Mild renal impairment
Allow for calcium and vitamin D intake from other sources
Preparation contains sucrose
Breastfeeding: Hypercalcaemia of infant possible if mother taking vitamin D
Check serum calcium level if nausea and vomiting occur
Monitor renal function on long term therapy
Monitor serum and urinary calcium in patients with sarcoidosis
Monitor serum calcium levels in patients with renal impairment
Monitor serum calcium levels on prolonged use
Reduce dose/temporarily withdraw treatment if hypercalcaemia occurs
Discontinue or reduce dose if renal impairment worsens
Pregnancy and Lactation
Use calcium with ergocalciferol with caution during pregnancy.
The manufacturer recommends that the use of calcium and ergocalciferol during pregnancy should only be under the direction of a physician and should only be used during the second and third trimester of pregnancy.
Use calcium with ergocalciferol with caution during breastfeeding.
Vitamin D and its metabolites pass in to breast milk. This should be taken into consideration when giving additional vitamin D to a child.
Breast milk from women taking pharmacological doses of vitamin D may cause hypercalcaemia if given to an infant. Serum calcium concentrations should be monitored in the breastfeeding neonate.
Low dose vitamin D (up to 10micrograms/400IU per day) can be taken by breastfeeding women. It helps ensure that the mother's requirements for vitamin D are met but also builds up adequate foetal stores for early infancy (Specialist Pharmacy Service).
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Last Full Review Date: July 2019
Summary of Product Characteristics: Calcium and Ergocalciferol tablets. Crescent Pharma Limited. September 2016.
NICE Evidence Services Available at: www.nice.org.uk Last accessed: 5 July 2019
Specialist Pharmacy Service (SPS)
Available at: https://www.sps.nhs.uk/
Safety in Lactation: Vitamins. Last revised: 19 April 2016
Last accessed: 5 July 2019
Already a member? Log in
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.